PV Bulletin

Early Alert: Breathing Circuit Issue from Draeger

Removal of VentStar Resus Neo hoses due to potential cracks affecting patient safety.

Primary source: What is an Early Alert?

PV Impact Brief

Urgency: HighConfidence: high

What changed

Draeger has recommended the immediate inspection and removal of VentStar Resus Neo hoses from use due to potential cracks that can compromise patient safety.

Why it matters

The presence of cracks in the VentStar Resus Neo hoses can result in restricted ventilation, hypoxia, or even patient death, making it crucial to ensure that all affected units are promptly identified and removed from use.

Action needed

Users must carefully inspect the VentStar Resus Neo hoses for damages as per the product's Instructions for Use (IFU) and discard any hoses showing signs of cracks or detachments before use.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 3, 2026

Full briefing

Practical implication

Users must carefully inspect the VentStar Resus Neo hoses for damages as per the product's Instructions for Use (IFU) and discard any hoses showing signs of cracks or detachments before use.

The FDA has issued an Early Alert regarding the VentStar Resus Neo breathing circuit hoses manufactured by Draeger. The alert recommends inspecting for cracks or detachments and removing affected units prior to use, as damaged hoses may lead to serious patient risks, including restricted ventilation and delayed therapy.

What changed: Draeger has recommended the immediate inspection and removal of VentStar Resus Neo hoses from use due to potential cracks that can compromise patient safety.

Why it matters: The presence of cracks in the VentStar Resus Neo hoses can result in restricted ventilation, hypoxia, or even patient death, making it crucial to ensure that all affected units are promptly identified and removed from use.

Practical implication: Users must carefully inspect the VentStar Resus Neo hoses for damages as per the product's Instructions for Use (IFU) and discard any hoses showing signs of cracks or detachments before use.

View original source

  • Source: FDA - MedWatch Safety Alerts RSS
  • Published at source: 2026-09-03T00:00:00.000Z
  • Discovered by monitor: 2026-09-03T21:47:54.015Z

Published from the regulator source ingestion pipeline after PV impact triage.

#Safety Signals#Usa#Regulator-monitor#Fda.gov#Safety Signal#Source-ingestion

Related updates for your role

publicFDA · USA · Updated Sep 2, 2026

Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound Catheters

Urgency: High

Immediate quarantine and destruction of all affected lots are mandated. Affected inventory must be checked, and customers must be notified if products have been resold or transferred.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicFDA · USA · Updated Sep 3, 2026

FDA Approves First Drug to Treat Alexander Disease

Urgency: High

Healthcare providers must implement the new administration protocol for Zanvastro, which is an injection every three months, and monitor for common side effects such as vomiting, back pain, and signs of aseptic meningitis.

LabelingLabeling Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Labeling Lead, Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency · European Union · Updated Sep 3, 2026

EudraVigilance - User Manual for Online Access

Urgency: High

Stakeholders must familiarize themselves with the new data elements for Individual Case Safety Reports (ICSRs) as per the revised EudraVigilance access policy effective immediately.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicEuropean Medicines Agency (EMA) · European Union · Updated Sep 2, 2026

Prasugrel Viatris (previously Prasugrel Mylan)

Urgency: High

Ensure that all labeling and safety information reflects the updated product name 'Prasugrel Viatris' instead of 'Prasugrel Mylan'.

LabelingLabeling Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Labeling Lead, Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward